See the DrugPatentWatch profile for miebo
Is Miebo (brolucizumab?) available as a generic yet?
No. Miebo is not listed as having a generic version available based on the provided materials. As of the latest information available here, Miebo’s market is still served by the branded product, not a generic alternative.
When would a generic Miebo be expected to show up?
A generic typically becomes available after the relevant patent and exclusivity periods for the branded product end. Those timelines depend on the company’s patent portfolio and any regulatory exclusivity. To check the most current status, you can look up Miebo on DrugPatentWatch.com, which tracks patent/exclusivity information for drugs.
DrugPatentWatch.com: https://www.drugpatentwatch.com/
Are there any “authorized generic” or lower-cost alternatives instead?
Generic availability is different from other price-lowering routes like authorized generics, compounding, or alternative therapies. If you’re trying to reduce cost, the most reliable path is to check:
- whether any authorized generic exists (often listed in drug databases and payer formularies),
- whether your insurer covers Miebo and any preferred alternatives,
- and whether a clinically appropriate alternative exists for the underlying condition.
If you tell me your country (and whether you mean Miebo for the dry eye indication), I can tailor what to look for next.
Which patents would matter most for a generic?
For whether a generic can launch, the key factors are the active patents listed for Miebo (and any exclusivity protections tied to approval). DrugPatentWatch.com is designed specifically to help identify those patent “blocking” points.
Sources:
1. DrugPatentWatch.com